Viewing StudyNCT00337376



Ignite Creation Date: 2024-05-05 @ 4:52 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00337376
Status: TERMINATED
Last Update Posted: 2014-01-14
First Post: 2006-06-13

Brief Title: A Study of the mTOR Inhibitor Rapamycin Rapamune Sirolimus in Combination With Abraxane in Advanced Solid Cancers
Sponsor: Yale University
Organization: Yale University

Organization Data

Organization: Yale University
Class: OTHER
Study ID: 0511000860
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Yale University
Lead Sponsor Class: OTHER
Responsible Party: Maysa Abu-Khalaf
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Yale University
Old Name: None
Old Organization: None

Collaborators

Name Class
Celgene Corporation INDUSTRY